Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Venetoclax-azacitidine in combination with chidamide and CAG versus daunorubicin and cytarabine in newly diagnosed AML

Lei Lv, Sai Huang, Qingyang Liu, Daihong Liu, Liping Dou

Blood (2025) 146 (Supplement 1): 3416.

https://doi.org/10.1182/blood-2025-3416

Published: 2025

Journal Articles

Ruxolitinib combined with decitabine-intensified modified busulfan/cyclophosphamide conditioning regimen reduces relapse after allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia

Daihong Liu, Liping Dou, Weiqi Li

Blood (2025) 146 (Supplement 1): 5969.

https://doi.org/10.1182/blood-2025-5969

Published: 2025

Journal Articles

Comparative clinical outcomes of offspring versus matched sibling donor hematopoietic stem cell transplantation in adults aged over 40 years with acute leukemia or Myelodysplastic Syndromes

Yujun Wei, Jingwen Tang, Liping Dou, Daihong Liu

Blood (2025) 146 (Supplement 1): 7796.

https://doi.org/10.1182/blood-2025-7796

Published: 2025

Journal Articles

HOXA9/METTL3/BMI1 axis is required for promoting anthracycline resistance in acute myeloid leukemia cells by modulating BMI1 expression through mRNA m6A modification

Hao Wang, Daihong Liu, Liping Dou

Blood (2025) 146 (Supplement 1): 5246.

https://doi.org/10.1182/blood-2025-5246

Published: 2025

Journal Articles

Pharmacokinetics-guided ATG targeted dosing strategy in unmanipulated haploidentical haematopoietic stem cell transplantation: A randomized, multicenter, phase 3 clinical trial

Daihong Liu, Liping Dou, haoyang zhang

Blood (2025) 146 (Supplement 1): 2447.

https://doi.org/10.1182/blood-2025-2447

Published: 2025

Journal Articles

Mesenchymal stem cells for treating gastrointestinal-involved steroid-refractory acute graft-versus-host disease: A multicenter, single-arm, pivotal clinical Trial

Yawei Zheng, Lu Wang, Xiaodong Mo, Yuanyuan Zhang, Yuhang Li, Mingzhe Han, Donglin Yang, Xiaohui Zhang, Daihong Liu, Erlie Jiang

Blood (2025) 146 (Supplement 1): 4237.

https://doi.org/10.1182/blood-2025-4237

Published: 2025

Journal Articles

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Blood (2025) 146 (Supplement 1): 120.

https://doi.org/10.1182/blood-2025-120

Published: 2025

Journal Articles

Synergistic effect of HLA evolutionary divergence and post-transplant biomarkers on non-relapse mortality prediction in adult haploidentical hematopoietic stem cell transplantation

Liping Dou, Di Guan, Yang-Liu Shao, Xiaobo Li, Ziqi Wang, Jingbo Wang, Yimei Feng, Xi Zhang, Xiangjun Liu, Daihong Liu

Blood (2025) 146 (Supplement 1): 2474.

https://doi.org/10.1182/blood-2025-2474

Published: 2025

Journal Articles

Venetoclax combined with cacag regimen as a bridge to allogeneic hematopoietic stem cell transplantation in patients with previously untreated acute myeloid leukemia achieving CR1

Daihong Liu, Liping Dou, Yu Fang

Blood (2025) 146 (Supplement 1): 6951.

https://doi.org/10.1182/blood-2025-6951

Published: 2025

Journal Articles

Fus::ERG fusion represents adverse-plus risk group in AML patients: Evidence from a registry-based matched cohort Study

Yi-Han Yang, Meng Lv, Jia Chen, Jing Liu, Xiaohui Zhang, Lanping Xu, Xi Zhang, Daihong Liu, Depei Wu, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 1706.

https://doi.org/10.1182/blood-2025-1706

Published: 2025

Journal Articles

A Pragmatic Monitoring Model for Non-Relapse Mortality Risk Based on Machine Learning in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

Yang-Liu Shao, Jingjing Yang, Xiaobo Li, Di Guan, Xiawei Zhang, Wu Tong, Zeliang Song, Dao Wang, Zhijie Wei, Jingbo Wang, Xiangjun Liu, Yuelin He, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 3573.

https://doi.org/10.1182/blood-2024-203190

Published: 2024

Journal Articles

CMV-Specific TCR-T Cells for the Treatment of CMV Reactivation after Allogeneic Hematopoietic Stem-Cell Transplantation

Jingwen Tang, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 3462.

https://doi.org/10.1182/blood-2024-204804

Published: 2024

Journal Articles

Lymphocyte Dynamics during the Treatment of SR-aGVHD with Mesenchymal Stem Cells Derived from Human Umbilical Cord Blood - a Phase III, Multi-Center, Prospective, Single-Arm Pivotal Study

Sheng Chen, Dongxue Ge, Kun Qian, Jingwen Tang, Yujun Wei, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 2135.

https://doi.org/10.1182/blood-2024-204735

Published: 2024

Journal Articles

Phase Ⅱ Study of Chidamide in Combination with Dcag and Venetoclax for Refractory/Relapsed Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

Qingyang Liu, Yanan Wen, Xiawei Zhang, Wenjing Gao, Daihong Liu, Liping Dou

Blood (2024) 144 (Supplement 1): 6070.

https://doi.org/10.1182/blood-2024-204739

Published: 2024

Journal Articles

A Phase I Study of Chidamide in Combination with Dcag and Venetoclax in Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

Xiawei Zhang, Jingjing Yang, Sai Huang, Qingyang Liu, Liping Dou, Chunji Gao, Daihong Liu

Blood (2024) 144 (Supplement 1): 1519.

https://doi.org/10.1182/blood-2024-204782

Published: 2024

Journal Articles

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Blood (2023) 142 (Supplement 1): 1207.

https://doi.org/10.1182/blood-2023-181622

Published: 2023

Journal Articles

Individualized Dosing of Anti-Thymocyte Globulin Led to Reduced CMV/EBV Reactivation and Superior Overall Survival in Adult Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation: A Prospective Phase II Study

Haitao Wang, Liping Dou, Lili Wang, Bo Peng, Nan Wang, Yingxin Zhao, Jishan Du, Daihong Liu

Blood (2022) 140 (Supplement 1): 4753–4754.

https://doi.org/10.1182/blood-2022-158994

Published: 2022

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Achieves Long-Term Survival in Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

Blood (2022) 140 (Supplement 1): 2306–2307.

https://doi.org/10.1182/blood-2022-164637

Published: 2022

Journal Articles

Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation

Liping Dou, Yanli Zhao, Lei Deng, Fang Zhou, Nan Wang, Xiangshu Jin, Fei Li, Liangding Hu, Daihong Liu

Blood (2022) 140 (Supplement 1): 1381–1382.

https://doi.org/10.1182/blood-2022-158162

Published: 2022

Journal Articles

Prophylactic Modified Donor Lymphocyte Infusion after Allogeneic Peripheral Blood Stem Cell Transplantation for Very High-Risk Hematological Malignancies: Low Incidence of Relapse without Increasing the Risk of Graft-Versus-Host Disease

Xiaoning Gao, Shuhong Wang, Wenrong Huang, Honghua Li, Yu Jing, Liping Dou, Fei Li, Lili Wang, MD PhD, Xiaolin Lu, Jing Chen, MD, Lijun Wang, Xiangshu Jin, Li Yu, Daihong Liu

Blood (2017) 130 (Supplement 1): 2002.

https://doi.org/10.1182/blood.V130.Suppl_1.2002.2002

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Venetoclax-azacitidine in combination with chidamide and CAG versus daunorubicin and cytarabine in newly diagnosed AML

Ruxolitinib combined with decitabine-intensified modified busulfan/cyclophosphamide conditioning regimen reduces relapse after allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia

Comparative clinical outcomes of offspring versus matched sibling donor hematopoietic stem cell transplantation in adults aged over 40 years with acute leukemia or Myelodysplastic Syndromes

HOXA9/METTL3/BMI1 axis is required for promoting anthracycline resistance in acute myeloid leukemia cells by modulating BMI1 expression through mRNA m6A modification

Pharmacokinetics-guided ATG targeted dosing strategy in unmanipulated haploidentical haematopoietic stem cell transplantation: A randomized, multicenter, phase 3 clinical trial

Mesenchymal stem cells for treating gastrointestinal-involved steroid-refractory acute graft-versus-host disease: A multicenter, single-arm, pivotal clinical Trial

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Synergistic effect of HLA evolutionary divergence and post-transplant biomarkers on non-relapse mortality prediction in adult haploidentical hematopoietic stem cell transplantation

Venetoclax combined with cacag regimen as a bridge to allogeneic hematopoietic stem cell transplantation in patients with previously untreated acute myeloid leukemia achieving CR1

Fus::ERG fusion represents adverse-plus risk group in AML patients: Evidence from a registry-based matched cohort Study

A Pragmatic Monitoring Model for Non-Relapse Mortality Risk Based on Machine Learning in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

CMV-Specific TCR-T Cells for the Treatment of CMV Reactivation after Allogeneic Hematopoietic Stem-Cell Transplantation

Lymphocyte Dynamics during the Treatment of SR-aGVHD with Mesenchymal Stem Cells Derived from Human Umbilical Cord Blood - a Phase III, Multi-Center, Prospective, Single-Arm Pivotal Study

Phase Ⅱ Study of Chidamide in Combination with Dcag and Venetoclax for Refractory/Relapsed Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

A Phase I Study of Chidamide in Combination with Dcag and Venetoclax in Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Individualized Dosing of Anti-Thymocyte Globulin Led to Reduced CMV/EBV Reactivation and Superior Overall Survival in Adult Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation: A Prospective Phase II Study

Allogeneic Hematopoietic Stem Cell Transplantation Achieves Long-Term Survival in Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation

Prophylactic Modified Donor Lymphocyte Infusion after Allogeneic Peripheral Blood Stem Cell Transplantation for Very High-Risk Hematological Malignancies: Low Incidence of Relapse without Increasing the Risk of Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only